Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Neurologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Available at: http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html. Accessed February 21, 2015.
- The use of alternative medicine by patients with amyotrophic lateral sclerosis.J Neurol Sci. 2001; 191: 151-154
- The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis.J Herb Pharmacother. 2005; 5: 23-31
- Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2009; 73: 1218-1226
- Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review).Neurology. 2009; 73: 1227-1233
- Palliative care issues in amyotrophic lateral sclerosis: an evidence based review.Am J Hosp Palliat Care. 2014; ([Epub ahead of print])
Available at: https://www.google.com/#q=als+treatment. Accessed February 17, 2015.
- Olfactory ensheathing glia injections in Beijing: misleading patients with ALS.Amyotroph Lateral Scler. 2007; 8: 314-316
- No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS.Amyotroph Lateral Scler. 2010; 11: 328-330
- Scrutinizing enrollment in ALS trials: room for improvement?.Amyotroph Lateral Scler. 2008; 9: 257-265
- Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.Am J Clin Nutr. 1996; 63: 130-137
- Nutritional assessment and survival in ALS patients.Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 91-96
- Nutritional management in MND/ALS patients: an evidence based review.Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 72-83
- No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice.Brain Res. 1999; 833: 117-120
- Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse.Muscle Nerve. 2005; 31: 214-220
- Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.J Int Med Res. 2015; 43: 67-79
- Energy intake and amyotrophic lateral sclerosis.Neuromolecular Med. 2007; 9: 17-20
- Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.Proc Natl Acad Sci U S A. 2004; 27: 11159-11164
- Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients.J Neurol Neurosurg Psychiatry. 2011; 82: 628-634
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.Muscle Nerve. 2011; 44: 20-24
- Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis.PLoS One. 2013; 8: e67783
- Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.BMC Neurol. 2013; 13: 84
Symptom management and end of life care, in press.
- Nutritional treatment: theoretical and practical issues.in: Mitsumoto H. Przedborski S. Gordon P.H. Amyotrophic lateral sclerosis. Taylor & Francis, New York2006: 721-735
- The ALS Nutrition/NIPPV Study: design, feasibility, and initial results.Amyotroph Lateral Scler. 2011; 12: 17-25
- Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.Am J Clin Nutr. 2014; 99: 792-803
Available at: https://mednet.mc.uky.edu/alscalculator/. Accessed February 21, 2015.
- A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis.BMC Neurosci. 2006; 7: 29
- High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study.Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 533-536
- Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.Lancet. 2014; 383: 2065-2072
- The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.PLoS One. 2013; 8: e61626
- Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function.Gastrointest Endosc. 1994; 40: 463-469
- Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.J Neurol. 1995; 242: 695-698
- Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.J Neurol. 2015; 262: 849-858
- Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.J Neurol Neurosurg Psychiatry. 2004; 75: 645-647
Available at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148003.htm. Accessed February 14, 2015.
- Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999.Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 240-244
- Nutrition and dietary supplements in motor neuron disease.Phys Med Rehabil Clin N Am. 2008; 19: 573
- ALS Untangled No. 20: the Deanna protocol.Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 319-323
Available at: http://www.winningthefight.org/t/deanna-protocol. Accessed February 21, 2015.
- Metabolic therapy with Deanna Protocol supplementation delays disease, progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.PLoS One. 2014; 9: e103526
- Guidelines for preclinical animal research in ALS/MND: a consensus meeting.Amyotroph Lateral Scler. 2010; 11: 38-45
- Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.Neurochem Res. 2006; 31: 1263-1269
- Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.Proc Natl Acad Sci U S A. 1998; 95: 8892-8897
- Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.Neurology. 2005; 65: 1834-1836
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.Ann Neurol. 2009; 66: 235-244
- Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.Neuromolecular Med. 2008; 10: 275-290
- Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.J Neurochem. 2001; 77: 383-390
- Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.Neurobiol Dis. 2003; 13: 264-272
- Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS.Amyotroph Lateral Scler. 2008; 9: 266-272
- A randomized sequential trial of creatine in amyotrophic lateral sclerosis.Ann Neurol. 2003; 53: 437-445
- Creatine for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2012; (CD005225)
- A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis.Amyotroph Lateral Scler. 2010; 11: 508-513
- Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.PLoS One. 2012; 7: e36153
- Co-enzyme Q10 and idebenone use in Friedreich's ataxia.J Neurochem. 2013; 126: 125-141
- Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?.J Bioenerg Biomembr. 2015; 47: 111-118
- Antioxidant and antiradical activities of L-carnitine.Life Sci. 2006; 18: 803-811
- L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.Brain Res. 2006; 1070: 206-214
- Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 397-405
- Omega-3 polyunsaturated fatty acids and human health outcomes.Biofactors. 2009; 35: 266-272
- Neurological benefits of omega-3 fatty acids.Neuromolecular Med. 2008; 10: 219-235
- Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.JAMA Neurol. 2014; 71: 1102-1110
- Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.Neurotherapeutics. 2014; 11: 419-432
- Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.Biomed Res Int. 2014; 2014: 483501
- Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: overlapping effects or limited therapeutic opportunity?.Orphanet J Rare Dis. 2014; 9: 78
- The pharmacology of resveratrol in animals and humans.Biochim Biophys Acta. 2015; 31: S0925-S4439
- Serum levels of beta-carotene, alpha-carotene, and vitamin A in patients with amyotrophic lateral sclerosis.Acta Neurol Scand. 1999; 99: 315-317
- Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis.Muscle Nerve. 2009; 39: 548-552
- Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.Trends Neurosci. 2003; 26: 137-146
- Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.Neurology. 2008; 70: 222-225
- Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.Eur J Neurol. 2010; 17: 84-89
- Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.Neuropharmacology. 2008; 54: 1112-1119
- Methyl vitamin B12 but not methylfolate rescues a motor neuron-like cell line from homocysteine-mediated cell death.Toxicol Appl Pharmacol. 2011; 251: 217-225
- Galactooligosaccharide improves the animal survival and alleviates motor neuron death in SOD1G93A mouse model of amyotrophic lateral sclerosis.Neuroscience. 2013; 246: 281-290
- Thiamin monophosphate in the CSF of patients with amyotrophic lateral sclerosis.Arch Neurol. 1982; 39: 507-509
- Inversion of T/TMP ratio in ALS: a specific finding?.Ital J Neurol Sci. 1986; 7: 333-335
- Light therapy and supplementary riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS).Lasers Surg Med. 2009; 41: 52-59
- Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.Ann Neurol. 2013; 73: 236-245
- Can vitamin D delay the progression of ALS?.Med Hypotheses. 2011; 76: 643-645
- Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis.Neurobiol Aging. 2014; 35: 1198-1205
- Dietary vitamin D3 supplementation at 10x the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.CNS Neurosci Ther. 2012; 18: 547-557
- Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.PLoS One. 2013; 8: e30243
- Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.PLoS One. 2011; 6: e29354
- Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.J Clin Neurosci. 2013; 20: 1550-1553
- ALSUntangled No. 24: vitamin D.Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 318-320
- Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.Ann Neurol. 1996; 39: 147-157
- A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol study group.Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 2: 9-18
- High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.J Neural Transm. 2005; 112: 649-660
- Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.Am J Epidemiol. 2011; 173: 595-602
- ALSUntangled No. 16: cannabis.Amyotroph Lateral Scler. 2012; 13: 400-404
- AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.Eur J Pharmacol. 2006; 542: 100-105
- The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.J Neurochem. 2007; 101: 87-98
- Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 33-39
- Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 182-184
- Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.Amyotroph Lateral Scler. 2009; 19: 1-8
- Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.FASEB J. 2006; 20: 1003-1005
- The endocannabinoid system in amyotrophic lateral sclerosis.Curr Pharm Des. 2008; 14: 2306-2316
- Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.Eur J Neurosci. 2008; 27: 572-579
- Endocannabinoids accumulate in spinal cord of SOD1 transgenic mice.J Neurochem. 2004; 89: 1555-1557
- Marijuana in the management of amyotrophic lateral sclerosis.Am J Hosp Palliat Care. 2001; 18: 264-270
- A pilot study of safety and tolerability of Delta 9-THC (Marinol) treatment for ALS.Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3: 23
- Survey of cannabis use in patients with amyotrophic lateral sclerosis.Am J Hosp Palliat Care. 2004; 21: 95-104
- Cannabis and amyotrophic lateral sclerosis: practical and hypothetical applications, and a call for clinical trials.Am J Hosp Palliat Care. 2010; 27: 347-356
- The endocannabinoid system: a putative role in neurodegenerative diseases.Int J High Risk Behav Addict. 2013; 2: 100-106
- Molecular biology of cannabinoid receptors.Handb Exp Pharmacol. 2005; 168: 81-115
- Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.J Biol Chem. 2004; 279: 48024-48037
- Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction.J Pharmacol Exp Ther. 2008; 325: 341-348
- Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms.J Biol Chem. 2007; 282: 25100-25113
- Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity.Neurosci Lett. 2001; 309: 197-201
- The cannabinoid system and cytokine network.Proc Soc Exp Biol Med. 2000; 225: 1-8
- Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.Expert Opin Investig Drugs. 2000; 9: 1553-1571
- Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry.Anal Bioanal Chem. 2014; 406: 7549-7560
- Early phytocannabinoid chemistry to endocannabinoids and beyond.Nat Rev Neurosci. 2014; 15: 757-764
- Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.J Neuroimmune Pharmacol. 2010; 5: 103-121
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.Br J Pharmacol. 2011; 163: 1344-1364
- Pharmacological actions of cannabinoids.Handb Exp Pharmacol. 2005; 168: 1-51
- Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate antinociception induced by transcutaneous electrostimulation of the peripheral nervous system.J Neurol Sci. 2014; 347: 82-89
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.Drug Metab Rev. 2014; 46: 86-95
- Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Drug Alcohol Depend. 2014; 1: 12-41
- Cannabis: pharmacology and toxicology in animals and humans.Addiction. 1996; 91: 1585-1614
- Cannabinoids and neurodegenerative diseases.CNS Neurol Disord Drug Targets. 2009; 8: 440-450
- An analgesia circuit activated by cannabinoids.Nature. 1998; 395: 381-383
- Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.Pain. 1991; 47: 95-103
- The analgesic potential of cannabinoids.J Opioid Manag. 2009; 5: 341-357
- Systematic review and meta-analysis of cannabis treatment for chronic pain.Pain Med. 2009; 10: 1353-1368
- Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.Br J Clin Pharmacol. 2011; 72: 735-744
- The endocannabinoid system, cannabinoids, and pain.Rambam Maimonides Med J. 2013; 4: e0022
- A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability.Neuropsychopharmacology. 2009; 34: 2368-2375
- Spinal and supraspinal components of cannabinoid-induced antinociception.J Pharmacol Exp Ther. 1991; 258: 517-523
- Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.Eur J Neurol. 2007; 14: 290-296
- (2012) Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.CMAJ. 2012; 184: 1143-1150
- Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.Neurology. 2014; 82: 1556-1563
- Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.Neurology. 2014; 82: 1083-1092
- Medical marijuana: rational guidelines for dosing.IDrugs. 2004; 7: 464-470
- Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol[(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.Fed Regist. 1999; 64: 35928-35930
- Enforcement in a series of medical cannabis patients.J Nerv Ment Dis. 2013; 201: 292-303
Available at: http://en.wikipedia.org/wiki/Acupuncture. Accessed March 3, 2015.
- Acupuncture-a critical analysis.J Intern Med. 2006; 259: 125-137
Available at: http://www.drmihaly-acupuncture.com/chinese-scalp-acupuncture-als.html. Accessed March 7, 2015.
Available at: http://www.hughsacupuncture.com/als-treatment-by-acupuncture-and-traditional-chinese-medicine/. Accessed March 7, 2015.
Available at: http://www.taoiststudy.com/content/use-qigong-herbal-medicine-achieve-cure-als. Accessed March 7, 2015.
- Acupuncture points and meridians do not exist.Sci Rev Alternative Med. 2001; 5: 143-148
- Integrative oncology: really the best of both worlds?.Nat Rev Cancer. 2014; 2014: 692-700
- The influence of sensory stimulation (acupuncture) on the release of neuropeptides in the saliva of healthy subjects.Life Sci. 1998; 63: 659-674
- Acupuncture stimulation and neuroendocrine regulation.Int Rev Neurobiol. 2013; 111: 125-140
- Acupuncture and endorphins.Neurosci Lett. 2004; 361: 236-240
- Substance P and beta-endorphin mediate electro-acupuncture induced analgesia in mouse cancer pain model.J Exp Clin Cancer Res. 2009; 28: 102
- Opioids and the immune system: what is their role?.Br J Pharmacol. 2011; 16: 1826-1828
- Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease.J Neuroimmunol. 1994; 51: 169-176
- Opioids, opioid receptors and the immune response.Drug Alcohol Depend. 2001; 62: 111-123
- The dual roles of immunity and ALS: injury overrides protection.Neurobiol Dis. 2015; 77: 1-12
- Protective and toxic neuroinflammation in amyotrophic lateral sclerosis.Neurotherapeutics. 2015; 12: 364-375
- Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI.Hum Brain Mapp. 2005; 24: 193-205
- Neuronal specificity of acupuncture response: an fMRI study with electroacupuncture.Neuroimage. 2002; 16: 1028-1037
- Functional MRI in healthy subjects during acupuncture; different effects of needle rotation in real and false acupoints.Neuroradiology. 2004; 46: 359-362
- New findings of the correlation between acupoints and corresponding brain cortices using functional MRI.Proc Natl Acad Sci U S A. 1998; 95: 2670-2673
- Acupoint-specific fMRI patterns in human brain.Neurosci Lett. 2005; 383: 236-240
- Anti-inflammatory actions of acupuncture.Mediators Inflamm. 2003; 12: 59-69
- Acupuncture suppresses kainic acid-induced neuronal death and inflammatory events in mouse hippocampus.J Physiol Sci. 2012; 62: 377-383
- Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model.J Neuroimmunol. 2010; 223: 84-91
- Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis model.Neurodegener Dis. 2011; 8: 504-514
- Naloxone fails to reverse pain thresholds elevated by acupuncture.Pain. 1983; 16: 13-31
- Effectiveness of acupuncture for nonspecific chronic low back pain: a systematic review and meta-analysis.Spine (Phila Pa 1976). 2013; 38: 2124-2138
- Short-term effects of acupuncture and stretching on myofascial trigger point pain of the neck: a blinded, placebo-controlled RCT.Complement Ther Med. 2014; 22: 835-841
- Acupuncture provides short-term pain relief for patients in a total joint replacement program.Pain Med. 2015; 16: 1195-1203
- The effects of acupuncture after thyroid surgery: a randomized, controlled trial.Surgery. 2014; 156 ([discussion: 1612–3]): 1605-1612
- Acupuncture for spasticity after stroke: a systematic review and meta-analysis of randomized controlled trials.Evid Based Complement Alternat Med. 2015; 2015: 870398
- The effects of sa-am acupuncture treatment on respiratory parameters in amyotrophic lateral sclerosis.Evid Based Complement Alternat Med. 2013; 2013: 506317
- Formulating a therapeutic program with the governing vessel in treating 46 cases of ALS.Shanghai Journal of Moxibustion. 1998; 17: 43
- Clinical observation on 46 cases of ALS in consideration of the treatment principal breaking through the Dumai.Zhejiang Journal of Integrating Traditional Chinese and Western Medicine. 1999; 9: 16-17
Available at: http://www.itmonline.org/arts/als.htm. Accessed March 19, 2015.
- Significant neurological improvement in two patients with amyotrophic lateral sclerosis after 4 weeks of treatment with acupuncture injection point therapy using enercel.J Acupunct Meridian Stud. 2011; 4: 257-261
- ALSUntangled 28: acupuncture.Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16: 286-289
Available at: http://www.patientslikeme.com/treatment_evaluations/browse?brand=f&condition_id=9&id=213-acupuncture-side-effects-and-efficacy. Accessed March 21, 2015.
- Cardiac tamponade caused by acupuncture: a review of the literature.Int J Cardiol. 2011; 149: 287-289
- A rare complication of acupuncture: pneumothorax.Tuberk Toraks. 2014; 62: 316-318
- Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies.J Gastroenterol Hepatol. 2003; 18: 1231-1236
- Adverse events following acupuncture: a prospective survey of 32000 consultations with doctors and physiotherapists.BMJ. 2001; 323: 485-486
- Prospective investigation of adverse events in 97,733 patients.Arch Intern Med. 2004; 164: 104-105
- Patient reports of adverse events associated with acupuncture treatment: a prospective national survey.Qual Saf Health Care. 2004; 13: 349-355
- Chelation therapy for atherosclerotic cardiovascular disease.Cochrane Database Syst Rev. 2002; (CD002785)
- EDTA chelation therapy for cardiovascular disease: a systematic review.BMC Cardiovasc Disord. 2005; 5: 32
- Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review.Amyotroph Lateral Scler. 2009; 10: 302-309
- The association of exposure to lead, mercury, and selenium in the development of amyotrophic lateral sclerosis and the epigenetic implications.Neurodegener Dis. 2011; 8: 1-8
- ALS and mercury intoxication: a relationship?.Clin Neurol Neurosurg. 2007; 109: 880-883
- Lead intoxication and amyotrophic lateral sclerosis.Rev Neurol (Paris). 1998; 154 ([in French]): 345-347
- Urinary excretion of lead and mercury after oral administration of meso-2,3-dimercaptosuccinic acid in patients with motor neurone disease.Int Arch Occup Environ Health. 1995; 67: 135-138
Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5508a3.htm. Accessed March 25, 2015.
- A pragmatic, three-arm randomised controlled trial of spiritual healing for asthma in primary care.Br J Gen Pract. 2006; 56: 444-449
- Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: a multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer.Am Heart J. 2006; 151: 934-942
- Therapeutic touch for healing acute wounds.Cochrane Database Syst Rev. 2014; (CD002766)
- Reiki therapy for postoperative oral pain in pediatric patients: pilot data from a double-blind, randomized clinical trial.Complement Ther Clin Pract. 2014; 20: 21-25
- A randomized placebo-controlled pilot study of the impact of healing touch on fatigue in breast cancer patients undergoing radiation therapy.Integr Cancer Ther. 2014; 13: 105-113
- Therapeutic touch is not therapeutic for procedural pain in very preterm neonates: a randomized trial.Clin J Pain. 2013; 29: 824-829
- ALSUntangled 12: Dean Kraft, energy healer.Amyotroph Lateral Scler. 2011; 12: 389-391
- A patient with motor neuron syndrome clinically similar to amyotrophic lateral sclerosis presenting a spontaneous recovery.Rinsho Shinkeigaku. 2000; 40: 1090-1095
- Reversible motor neuron disease.Eur Neurol. 1993; 33: 387-389
- Subacute, reversible motor neuron disease.Neurology. 1991; 41: 1541-1544
- Distant healing–an “update” of a systematic review.Wien Klin Wochenschr. 2003; 115: 241-245
- Complementary treatment: who cares how it works, as long as it does?.Lancet Oncol. 2005; 6: 131-132
- Spiritual healing: more than meets the eye.J Pain Symptom Manage. 2006; 32: 393-395
- Four models of the physician-patient relationship.JAMA. 1992; 267: 2221-2226
- Information-seeking behavior among people with motor neuron disease.Br J Nurs. 2004; 13: 964-968
- History and development of the doctrine of informed consent.Int Electron J Health Educ. 2001; 4: 41-47
- ALSUntangled: a scientific approach to off-label treatment options for patients with ALS using tweets and twitters.Amyotroph Lateral Scler. 2009; 3: 129-130
- Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations.Health Expect. 2007; 3: 248-258
- Clinical decision-making: physicians’ preferences and experiences.BMC Fam Pract. 2007; 8: 10
- Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.Psychother Psychosom. 2008; 77: 219-226
- ALSUntangled: introducing the table of evidence.Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16: 142-145
- ALSUntangled No. 19: sodium chlorite.Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 236-238
Article info
Publication history
Published online: September 07, 2015
Footnotes
Disclosure statement: Dr R.S. Bedlack has received research support from the ALS Association and Motor Neurone Disease Association for ALSUntangled, and is a consultant for Neuraltus Pharmaceuticals. Dr S. Paganoni is funded by an NIH Career Development Award (2K12HD001097-16).
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
